{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "Kristina Bennet Emdal"}, {"accession": "MS:1000589", "name": "contact email", "value": "kristina.emdal@cpr.ku.dk"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "NNF Center for Protein Research, Proteomics Program, Faculty of Health and Medical Sciences, University of Copenhagen."}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Jesper V. Olsen"}, {"accession": "MS:1000589", "name": "contact email", "value": "jesper.olsen@cpr.ku.dk"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Novo Nordisk Foundation Center for Protein Research, Faculty of Health & Medical Sciences, University of Copenhagen, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark"}]}], "datasetFiles": [{"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD009477/20180112_QE3_nLC7_DBJ_SA_TMT11phos_ALK_3mg_01.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD009477/20180112_QE3_nLC7_DBJ_SA_TMT11phos_ALK_3mg_02.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD009477/20180112_QE3_nLC7_DBJ_SA_TMT11phos_ALK_3mg_03.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD009477/20180112_QE3_nLC7_DBJ_SA_TMT11phos_ALK_3mg_04.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD009477/20180112_QE3_nLC7_DBJ_SA_TMT11phos_ALK_3mg_05.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD009477/20180112_QE3_nLC7_DBJ_SA_TMT11phos_ALK_3mg_06.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD009477/20180112_QE3_nLC7_DBJ_SA_TMT11phos_ALK_3mg_07.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD009477/20180112_QE3_nLC7_DBJ_SA_TMT11phos_ALK_3mg_08.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD009477/20180112_QE3_nLC7_DBJ_SA_TMT11phos_ALK_3mg_09.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD009477/20180112_QE3_nLC7_DBJ_SA_TMT11phos_ALK_3mg_10.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD009477/20180112_QE3_nLC7_DBJ_SA_TMT11phos_ALK_3mg_11.raw"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD009477/20180112_QE3_nLC7_DBJ_SA_TMT11phos_ALK_3mg_12.raw"}, {"accession": "MS:1002849", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD009477/MaxQuantOutput.tar.gz"}], "description": "We used mass spectrometry-based proteomics to unravel anaplastic lymphoma kinase (ALK) signaling in the ALK and MYCN amplified neuroblastoma cell line, NB1. We specifically measured the ALK phosphoproteome upon siRNA depletion of ALK and upon ALK inhibition using the ALK-targeting small-molecule inhibitor lorlatinib. For quantitative phosphoproteomics we used a tandem mass tag (TMT)-based approach. Conditions for the TMT 11-plex setup is specified below. For each siRNA depletion experiment, NB1 cells were treated with siRNA (80 nM; as specified below) for 48 hours prior to stimulation with 0.1% DMSO for 30 minutes. For inhibitor treatment, NB1 cells were treated for 30 minutes with either 10 microM or 10 nM lorlatinib.  The experimental treatment conditions and TMT11-plex labeling are specified below:  126: siControl replicate 1, 0.1% DMSO 127N: siControl replicate 2, 0.1% DMSO 127C: siControl replicate 3, 0.1% DMSO 128N: siALK sequence 1, 0.1% DMSO 128C: siALK sequence 2, 0.1% DMSO 129N: siALK mix of sequence 1 and 2, 0.1% DMSO 129C: 10 microM lorlatinib replicate 1  130N: 10 microM lorlatinib replicate 2 130C: 10 microM lorlatinib replicate 3 131N: 10 nM lorlatinib replicate 1 131C: 10 nM lorlatinib replicate 2", "fullDatasetLinks": [{"accession": "MS:1002852", "name": "Dataset FTP location", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD009477"}, {"accession": "MS:1001930", "name": "PRIDE project URI", "value": "http://www.ebi.ac.uk/pride/archive/projects/PXD009477"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD009477"}, {"accession": "MS:1001921", "name": "ProteomeXchange accession number version number", "value": "2"}], "instruments": [{"accession": "MS:1001911", "name": "Q Exactive"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "human, neuroblastoma, ALK signaling, LC-MSMS"}, {"accession": "MS:1001926", "name": "curator keyword", "value": "Biomedical"}], "modifications": [{"accession": "MOD:00696", "name": "phosphorylated residue"}], "publications": [{"terms": [{"accession": "MS:1000879", "name": "PubMed identifier", "value": "30459283"}, {"accession": "MS:1002866", "name": "Reference", "value": "Emdal KB, Pedersen AK, Bekker-Jensen DB, Lundby A, Claeys S, De Preter K, Speleman F, Francavilla C, Olsen JV. Integrated proximal proteomics reveals IRS2 as a determinant of cell survival in ALK-driven neuroblastoma. Sci Signal. 2018 11(557)"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens (Human)"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "Phosphoroteomics analysis of ALK signaling in neuroblastoma cells"}